NeuX Technologies
Fred Beyerlein is a Strategic Business Advisor at NeuX Technologies. Fred has also served as President & CEO of Rubicon Genomics, and as a Member of the Advisory Board at Axios Biosciences. In addition, they were the CEO of nanoRETE, Inc., and an Advisor at the Emerging Technology Accelerator. Fred is currently a Principal at FGB Technologies, LLC.
Fred Beyerlein has an MBA in finance and economics from Fordham Gabelli School of Business, and a BS in industrial relations/economics from the University of Bridgeport.
This person is not in the org chart
This person is not in any offices
NeuX Technologies
NeuX is optimizing the human condition by attempting to increase human performance, quickly heal injuries, and successfully treat chronic pain.